Revolutionary Hypo-tec Needlestick Injury Prevention Product enters North American market

Oct 8 2014

V3 Healthcare Strategies, a Wisconsin-based Accountable Care Strategies company, announced the North American launch of the revolutionary Hypo-tec Needlestick Injury Prevention Product amidst an environment of infectious catastrophic diseases such as Ebola, Hanta & Hemorrhagic Fevers, while simultaneously protecting against all other infectious diseases such as HIV/AIDS, Hepatitis and more. According to Dr. Paul A. Markham, President, "This North American launch of Hypo-tec^TM brings forth a patented, revolutionary, timely, clinician-centered approach to sharps needlestick safety. Hypo-tec^TM enters the North American market following wide scale acceptance in the United Kingdom. With a deep heritage in providing solutions for Mad Cow disease in the UK, Hypo-tec designers constantly deliver unique solutions to improve safety, clinician productivity in lockstep with current Care Coordination Requirements. All V3 products such as Hypo-tec^TM, reinforce a sincere commitment to improving safety and patient outcomes, while avoiding unnecessary costs, in conjunction with the Accountable Care Act (PPACA)." Hypo-tec^TM provides a simple, cost‐effective solution to an everyday problem using a shielded needle to allow safe access through the 'rubber' bung.

• No risk of needlestick injury
• No risk of spillage
• No risk of contamination
• Prevents accidental puncture of the bag tail which can occur using an exposed hypodermic needle.

"Given the current transformation of healthcare and the encroaching threat of Ebola and other infectious diseases in North America, this comprehensive clinician-centered form of sharps safety, changes the game for providers and insurance companies. The concept has the potential to impact shared saving plans in Accountable Care Organizations, while also positively impacting health insurance indicators such as HEDIS, with regards to Medicare Advantage Star Rating programs," as stated by Dr. Paul A. Markham President of V3 Healthcare Strategies. The result is reduced cost to healthcare systems and ultimately to the American healthcare consumer.

SOURCE V3 Healthcare Strategies